참고문헌
- Aruoma OI, Grootveld M, Bahorun T (2006). Free radicals in biology and medicine: from inflammation to bioteclmology. Biofactors, 27, 1-3. https://doi.org/10.1002/biof.5520270101
- Berberat PO, Dambrauskas Z, Gulbinas A, et al (2005). Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res, 11, 3790-8. https://doi.org/10.1158/1078-0432.CCR-04-2159
- Chang KW, Lee TC, Yeh WI, et al (2004). Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer, 91, 1551-5. https://doi.org/10.1038/sj.bjc.6602186
- Chian S, Li YY, Wang XJ, et al (2014). Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac J Cancer Prev, 15, 2911-6. https://doi.org/10.7314/APJCP.2014.15.6.2911
- Datta D, Banerjee P, Gasser M, Waaga-Gasser AM, Pal S (2010). CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J BioI Chem, 285, 36842-8. https://doi.org/10.1074/jbc.M110.170324
- Davies KJ (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp, 61, 1-31.
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7 , 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Deshane J, Wright M, Agarwal A (2005). Heme oxygenase-1 expression in disease states. Acta Biochim Pol, 52, 273-84.
- Egger M, Davey Smith G, Sclmeider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Exner M, Minar E, Wagner 0, Schillinger M (2004). The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med, 37, 1097-104. https://doi.org/10.1016/j.freeradbiomed.2004.07.008
- Higgins JPT, Green S, eds (2009). Cochrane Handoook for Systematic Reviews of Interventions, Version 5.0.2 [Updated September 2009]. The Cochrane Collaooration, Oxford.
- Hirai H, Kubo H, Yamaya M, et al (2003). Microsatellite polymorphism in heme oxygenase-l gene promoter is associated with susceptibility to oxidant-induced apoptosis inlymphoblastoid cell lines. Blood, 102, 1619-24. https://doi.org/10.1182/blood-2002-12-3733
- Hong CC, Ambrosone CB, Ahn J, et al (2007). Genetic variability in iron-related oxidative stress pathways (Nrf2, NQO1, NOS3, and HO-1), ironintake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev , 16, 1784-94. https://doi.org/10.1158/1055-9965.EPI-07-0247
- Hu JL, Li ZY, Liu W, et al (2010). Polymorphism in heme oxygenase-l (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. Neoplasma, 57, 86-92. https://doi.org/10.4149/neo_2010_01_086
- Jiraskova A, Novotny J, Novotny L, et al (2012). Association of serum bilirubin and promoter variations in HMOX1and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer, 131, 1549-55. https://doi.org/10.1002/ijc.27412
- Jozkowicz A, Was H, Dulak J (2007). Heme oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal, 9, 2099-117. https://doi.org/10.1089/ars.2007.1659
- Kikuchi A, Yamaya M, Suzuki S, et al (2005). Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-l gene promoter polymorphism. Hum Genet, 116, 354-60. https://doi.org/10.1007/s00439-004-1162-2
- Kimpara T, TakedaA, Watanabe K, et al (1997). Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet, 100, 145-7. https://doi.org/10.1007/s004390050480
- Li Q, Wang JM, Peng Y, et al (2013). Association of DNA base-excision repair XRCC1 , OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5145-51. https://doi.org/10.7314/APJCP.2013.14.9.5145
- Li Y, Ambrosone CB, McCullough MJ, et al (2009). Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis, 30, 777-84. https://doi.org/10.1093/carcin/bgp053
- Lin SC, Liu CJ, Yeh WI, et al (2006). Functional polymorphism in NFKBl promoter is related to the risks of oral squamous cell carcinoma occuning on older male areca (betel) chewers. Cancer Lett, 243, 47-54. https://doi.org/10.1016/j.canlet.2005.11.019
- Lo SS, Lin SC, Wu CW, et al (2007). Heme Oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann Surg Oncol, 14, 2250-6. https://doi.org/10.1245/s10434-006-9290-7
- Luo H, Li Z, Qing Y, et al (2014). Single nucleotide polymorphisms of DNA base-excision repair genes (APEl, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 15, 1133-40. https://doi.org/10.7314/APJCP.2014.15.3.1133
- Maines MD (1997). The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol, 37,517-54. https://doi.org/10.1146/annurev.pharmtox.37.1.517
- Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
- Marcos M, Gomez-Munuera M, Pastor I, Gonzalez-Sanniento R, Laso FJ (2009). Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol, 170, 948-56. https://doi.org/10.1093/aje/kwp236
- Murakami A, Fujimori Y, Yoshikawa Y, et al (2012). Heme Oxygenase-1promoter polymorphism is associated with risk of malignant mesothelioma. Lung, 190, 333-7. https://doi.org/10.1007/s00408-012-9371-2
- Nulm P, Kunzli BM, Hennig R, et al (2009). Heme oxygenase-1 and its metaoolites affect pancreatic tumor growth in vivo. Mol Cancer, 8, 37 https://doi.org/10.1186/1476-4598-8-37
- Okamoto I, Krogler J, Endler G, et al (2006). A microsatellite polymorphism in the heme oxygenase-l gene promoteris associated withriskfor melanoma. Int J Cancer, 119, 1312-5. https://doi.org/10.1002/ijc.21937
- Sacca P, Meiss R, Casas G, et al (2007). Nuclear translocation of haeme oxygenase-l is associated to prostate cancer. Br J Cancer, 97, 1683-9. https://doi.org/10.1038/sj.bjc.6604081
- Sawa T, Mounawar M, Tatemichi M, et al (2008). Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-l and the inducible nitric oxide synthase gene promoters. Cancer Lell, 269, 78-84. https://doi.org/10.1016/j.canlet.2008.04.015
- Song F, Li X, Zhang M, et al (2009). Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol, 170, 747-56. https://doi.org/10.1093/aje/kwp196
- Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12. https://doi.org/10.1001/jama.283.15.2008
- Vashist YK, Uzunoglu G, Cataldegirmen G, et al (2009). Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour. Histopathology, 54, 303-8. https://doi.org/10.1111/j.1365-2559.2009.03221.x
- Vashist YK, Uzungolu G, Kutup A, et al (2011). Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer. J Surg Oncol, 104, 305-11 https://doi.org/10.1002/jso.21926
- Woolf B (1955). On estimating the relation between blcxxl group and disease. Ann Hum Genet, 19,251-3. https://doi.org/10.1111/j.1469-1809.1955.tb01348.x
- Yamada N, Yamaya M, Okinaga S, et al (2000). Microsatellite polymorphism in the heme oxygenase-l gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 66, 187-95. https://doi.org/10.1086/302729
피인용 문헌
- Heme oxygenase-1: emerging target of cancer therapy vol.22, pp.1, 2015, https://doi.org/10.1186/s12929-015-0128-0
- repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma vol.136, pp.8, 2016, https://doi.org/10.3109/00016489.2016.1157265
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism vol.73, pp.17, 2016, https://doi.org/10.1007/s00018-016-2223-0
- Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagus vol.90, pp.4, 2016, https://doi.org/10.1111/cge.12765
- Functional Mechanisms of Microsatellite DNA in Eukaryotic Genomes vol.9, pp.9, 2017, https://doi.org/10.1093/gbe/evx164
- Effect of heme oxygenase-1 gene promoter polymorphism on cancer risk by histological subtype: A prospective study in arseniasis-endemic areas in Taiwan vol.138, pp.8, 2015, https://doi.org/10.1002/ijc.29926